01/21/2026
Researchers have found that a new imaging oral agent, also known as a "contrast agent," helps radiologists better see bowel structures and disease in CT imaging when compared with the current oral contrast agents.
Findings suggest this new agent significantly improves visualization of inflammatory bowel disease (IBD) or cancer within the abdomen, and may provide earlier and more confident diagnoses.
Learn more: https://mayocl.in/49wkkmL